MRPL51

Chr 12

mitochondrial ribosomal protein L51

Also known as: CDA09, HSPC241, MRP64, bMRP64, mL51

The protein is a component of the large 39S subunit of mitochondrial ribosomes, which synthesize proteins within mitochondria. Mutations cause Combined Oxidative Phosphorylation Deficiency 51, a severe mitochondrial disorder with autosomal recessive inheritance that typically presents in infancy with developmental delay, seizures, and lactic acidosis. The gene shows low constraint against loss-of-function variants (pLI 0.03), consistent with recessive inheritance where heterozygous carriers are typically unaffected.

Summary from RefSeq
Research Assistant →
0
Active trials
1
Pubs (1 yr)
45
P/LP submissions
0%
P/LP missense
1.26
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryMRPL51
Population Constraint (gnomAD)
Low constraint (pLI 0.03) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
45 unique Pathogenic / Likely Pathogenic· 32 VUS of 89 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.26LOEUF
pLI 0.033
Z-score 1.17
OE 0.49 (0.221.26)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.19Z-score
OE missense 0.94 (0.781.14)
74 obs / 78.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.49 (0.221.26)
00.351.4
Missense OE0.94 (0.781.14)
00.61.4
Synonymous OE1.36
01.21.6
LoF obs/exp: 3 / 6.1Missense obs/exp: 74 / 78.9Syn Z: -1.46
DN
0.7132th %ile
GOF
0.6344th %ile
LOF
0.3258th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

89 submitted variants in ClinVar

Classification Summary

Pathogenic42
Likely Pathogenic3
VUS32
42
Pathogenic
3
Likely Pathogenic
32
VUS

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
42
0
42
Likely Pathogenic
0
0
3
0
3
VUS
0
21
11
0
32
Likely Benign
0
0
0
0
0
Benign
0
0
0
0
0
Total02156077

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MRPL51 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →